| | | | | Major Chinese frozen food producer Sanquan Food Co Ltd said on Monday it has recalled products that may be contaminated with African swine fever, following media reports that some of its dumplings tested positive for the virus. | | |
| | | Japanese scientists will test the use of human-induced pluripotent stem cells (iPS) to treat spinal cord injuries, a health ministry panel that approved the research project said on Monday. | | |
| | | A combination of Merck & Co's immunotherapy Keytruda and Pfizer Inc's Inlyta helped patients with advanced kidney cancer live longer than those receiving and older Pfizer standalone therapy, according to data from a late-stage study presented on Saturday. | | |
| | | Only half of France's farmland could do without glyphosate-based weed-killers by 2021, the country's farm minister suggested, further lowering an initial ambition to get rid of the controversial chemical by then. | | |
| | | Indonesia will push back by as much as seven years an October deadline for halal labels on food, drugs and cosmetics, after industry voiced fears the move could bring chaos and threaten supplies of life-saving vaccines and other products. | | |
| | | The U.S. Centers for Medicare & Medicaid Services (CMS) on Friday proposed coverage of expensive CAR-T cell therapies at cancer centers that meet criteria including a registry or clinical study to monitor how well patients fare for at least two years after treatment. | | |
| | | Nektar Therapeutics said on Friday some patients with advanced bladder cancer treated with a combination of its experimental treatment and Bristol-Myers Squibb Co's immunotherapy, Opdivo, showed signs of tumor reduction in an early-stage study. | | |
| | | (Reuters Health) - School-age children with asthma who receive education on managing the condition may have fewer attacks, emergency room visits and hospitalizations than those who don't get such classes, a recent study suggests. | | |
| | | (Reuters Health) - Patients who discharge themselves from the hospital against medical advice are twice as likely to be back within 30 days as those who leave when doctors say they're ready, a large U.S. study finds. | | |
| | | (Reuters Health) - The number of push-ups a man can do in the doctor's office may be a good predictor of his risk of developing heart disease in the coming years, new research suggests. | | |
| | | (Reuters Health) - African-American adults who often struggle to pay bills may be more than twice as likely to develop heart disease than their counterparts who don't have much financial stress, a U.S. study suggests. | | |
|
| |
